• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS INTEGRA CREATININE PLUS VER.2 ASSAY; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/18/2023
Type of Reportable Event Malfunction
Event or Problem Description
There was an allegation of questionable crep2 creatinine plus ver.2 results for 2 patient samples on a cobas integra 400 plus.For sample 1, the initial crep2 result was 190.6 umol/l.The repeat result was 67.5 umol/l.For sample 2, the initial crep2 result was 101.7 umol/l.The first repeat result was 185.7 umol/l and the second repeat result was 101.7 umol/l.
 
Additional Manufacturer Narrative
The analyzer serial number is (b)(6).The calibration and qc recovery data provided was acceptable.The alarm trace showed multiple no fluid alarms.The field service engineer (fse) found that the distributor fluid transfer head had crystallization and was leaking and replaced it.The investigation is ongoing.
 
Additional Manufacturer Narrative
It was found that the customer was operating the analyzer with the front cover open which should be closed as the loaded reagents must be kept at 8 degrees centigrade.The investigation did not identify a product problem.The root cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS INTEGRA CREATININE PLUS VER.2 ASSAY
Common Device Name
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key17957104
Report Number1823260-2023-03336
Device Sequence Number5282723
Product Code JFY
UDI-Device Identifier04015630919215
UDI-Public04015630919215
Combination Product (Y/N)Y
Initial Reporter CountrySF
PMA/510(K) Number
K024098
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2023
Device Catalogue Number03263991190
Device Lot Number706163
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/19/2023
Supplement Date Received by Manufacturer11/13/2023
Initial Report FDA Received Date10/18/2023
Supplement Report FDA Received Date12/01/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age34 YR
Patient SexMale
-
-